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ABSTRACT 
 
Microarray  studies  have  shown  that  individual  synthetic  small  interfering  RNAs  (siRNAs)  can  have 
substantial off-target effects. Pools of siRNAs, produced by incubation of dsRNAs with recombinant Dicer 
or RNase III, can also be used to silence genes. Here we show that diced siRNA pools are highly complex, 
containing  hundreds  of  different  individual  siRNAs.  This  high  complexity  could  either  compound  the 
problem  of  off-target  effects,  since  the  number  of  potentially  problematic  siRNAs  is  high,  or  it  could 
diminish the problem, since the concentration of any individual problematic siRNA is low. We therefore 
compared  the  off-target  effects  of  diced  siRNAs  to  chemically  synthesized  siRNAs.  In  agreement  with 
previous  reports,  we  found  that  two  chemically  synthesized  siRNAs  targeted  against  p38α  MAPK 
(MAPK14) induced off-target changes in the abundance of hundreds of mRNAs. In contrast, three diced 
siRNA pools against p38α MAPK had almost no off-target effects. The off-target effects of a synthetic 
siRNA were reduced when the siRNA was diluted 3-fold in a diced pool and completely alleviated when it 
was diluted 30- or 300-fold, suggesting that when problematic siRNAs are present within a diced pool, their 
absolute concentration is too low to result in significant off-target effects. These data rationalize the observed 
high specificity of RNA interference in C. elegans and D. melanogaster, where gene suppression is mediated 
by endogenously-generated diced siRNA pools, and provide a strategy for improving the specificity of RNA 
interference experiments and screens in mammalian cells. 
 
KEYWORDS:  RNAi,  siRNA,  d-siRNA,  e-siRNA,  gene  silencing,  microarray,  mitogen  activated  protein 
kinase (MAPK) 
 
 
INTRODUCTION 
 
RNA  interference  (RNAi)  is  a  powerful  method  for 
carrying out loss-of-function studies in diverse organisms 
and cell types (Fire et al, 1998; Meister and Tuschl, 2004; 
Silva  et  al,  2004;  Tomari  and  Zamore,  2005).  Its 
usefulness and reliability is exemplified by  the fact that 
RNAi is frequently used for loss-of-function screening in 
organisms, like C. elegans (Gonczy et al, 2000; Ashrafi et 
al, 2003; Kamath and Ahringer, 2003; Kamath et al, 2003; 
Lee et al, 2003; Pothof et al, 2003; Simmer et al, 2003; 
Vastenhouw et al, 2003) and D. melanogaster (Kiger et al, 
2003; Boutros et al, 2004; Dasgupta and Perrimon, 2004; 
Eggert  et  al,  2004;  Cherry  et  al,  2005),  that  are  also 
amenable  to  classical  forward  and  reverse  genetic 
approaches. Moreover, RNAi has allowed loss-of-function 
experiments  and  screens  to  be  performed  in  vertebrate 
cells where alternative approaches are much more limited 
(Elbashir et al, 2001a; Brummelkamp et al, 2003; Kittler et 
al, 2004; Paddison et al, 2004). 
 
In vertebrate systems, RNAi is generally accomplished by 
the transfection or expression of small interfering RNAs 
(siRNAs),  which  avoids  the  non-specific  suppression  of  
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protein  synthesis  induced  by  larger  dsRNAs  in  many 
vertebrate cell types (Elbashir et al, 2001a). The antisense 
strand  of  the  siRNA  guides  RNA-induced  silencing 
complexes (RISC) to complementary mRNAs via nucleic 
acid  interactions  (Hammond  et  al,  2000;  Elbashir  et  al, 
2001b) and subsequently the mRNAs are cleaved by an 
endonuclease (Zamore et al, 2000; Liu et al, 2004; Song et 
al,  2004)  and  digested  to  single  nucleotides  by  an 
exonuclease (Caudy et al, 2003). 
 
Because base pairing is ordinarily very precise, the target 
specificity  of  siRNAs  could  be  very  high,  and  initial 
indications  were  that  this  was  the  case.  In  C.  elegans 
RNAi  phenotypes  correlate  well  with  true  genetic  null 
phenotypes  for  many  genes  (Fire  et  al,  1998).  In 
mammalian  cells,  studies  of  luciferase  reporter  genes 
indicated  high  specificity  of  siRNAs  for  their  intended 
targets as well; single base pair changes could abolish an 
siRNA’s ability to silence its target (Elbashir et al, 2001a). 
 
Recently, microarray analysis has been used to look more 
comprehensively for siRNA off-target effects. One group 
showed that an exogenous green fluorescent protein gene 
could be silenced with only small variations in the levels 
of endogenous mRNAs (mostly <2-fold) (Chi et al, 2003). 
Because  these  changes  were  inconsistent  between 
replicates, they were attributed to experimental noise (Chi 
et al, 2003). A second group silenced several endogenous 
targets and analyzed global mRNA changes by microarray 
analysis (Semizarov et al, 2003). As long as the siRNA 
concentration was less than 20 nM, different siRNAs to 
the  same  target  were  found  to  produce  similar  mRNA 
changes (Semizarov et al, 2003). This argued that most of 
the  changes  in  mRNA  levels  were  secondary  to  the 
reduction of the intended target, rather than unwanted off-
target effects (Semizarov et al, 2003). 
 
However, a third group found that siRNAs could trigger 
off-target  effects.  Each  of  eight  siRNAs  designed  to 
suppress p38α MAPK (also termed MAPK14) was found 
to also cause changes in the abundances of many other 
mRNAs  (Jackson  et  al,  2003).  Each  siRNA  affected  a 
different  subset  of  mRNAs,  implying  that  the  changes 
were sequence-specific off-target effects rather than non-
sequence-specific  toxic  effects  or  secondary  effects  of 
p38α  MAPK  suppression  (Jackson  et  al,  2003).  Off-
target effects could not be avoided by simply decreasing 
the  dose  of  siRNA  or  confining  the  experiment  to  a 
particular  time  window  (Jackson  et  al,  2003).  Similar 
results were found for a second target, IGF1R (insulin-
like growth factor receptor) (Jackson et al, 2003). These 
findings indicated that off-target effects might be fairly 
common  in  siRNA-treated  cells.  This  conclusion  was 
particularly  worrisome  in  light  of  the  exploding 
popularity  of  siRNA  approaches  for  loss-of-function 
experiments and screens. 
 
The prevailing hypothesis  is that many  of the off-target 
effects of siRNAs are mediated by cross-hybridization due 
to stretches of limited identity between the siRNAs and the 
off-target  genes.  This  suggests  a  number  of  potential 
strategies  for reducing  cross-hybridization  and  off-target 
effects.  Off-target  effects  resulting  from  the  passenger 
siRNA  strand  can  potentially  be  eliminated  by 
modifications that prevent its incorporation into the RISC.  
For  example,  chemically  modified  siRNAs  and  locked 
nucleic acids have been used to prevent passenger siRNA 
strand mediated RNA cleavage (Elmen et al, 2005; Judge 
et al, 2006).   
 
Recent studies on the sequence requirements for RNAi-
mediated  gene  silencing  have  suggested  ways  of 
decreasing off-target effects that are the result of cross-
hybridization between a transcript and either the guide 
or passenger strand of the siRNA. Both the number and 
position of mismatches between the siRNA strands and a 
cross-hybridizing  gene  affects  the  likelihood  of  off-
target silencing (Du et al, 2005; Holen et al, 2005). In 
general, mismatches within the core of the sequence are 
more detrimental to silencing than mismatches at either 
the  5’-  or  3’-end,  although  there  are  some  disparities 
regarding the importance of the 5’-end (Du et al, 2005; 
Holen et al, 2005).  
 
Additional studies found that 6 or 7 consecutive matches 
between the siRNA guide strand and the off-target RNA 
as well as the context of the matching sequence within 
the  off-target  RNA  are  important  parameters  that 
determine whether or not an off-target mRNA is cleaved 
(Lin et al, 2005; Birmingham et al, 2006).  In concert 
with in silico analyses of siRNA specificity (Huesken et 
al,  2005;  Qiu  et  al,  2005)  these  empirical measures  of 
specificity have resulted in siRNA design algorithms that 
avoid particular siRNA sequences that may decrease off-
target transcript abundance.   
 
In  addition,  there  may  be  off-target  effects  that  do  not 
depend upon cross-hybridization between the siRNA and 
the  off-target  genes  (Bridge  et  al,  2003;  Sioud  and 
Sorensen, 2003;  Sledz et al,  2003;  Kariko et al, 2004a; 
Kariko et al, 2004b; Persengiev et al, 2004; Judge et al, 
2005).  These  may  include  aptamer-like  effects  or  other 
poorly understood sequence-specific, cross-hybridization-
independent mechanisms. 
 
We and others have shown that complex pools of siRNAs 
can be produced by incubating in vitro transcribed long 
double  stranded  RNAs  (~500  bp)  with  recombinant 
bacterial RNase III (Yang et al, 2002; Kittler et al, 2005) 
or recombinant human Dicer (Provost et al, 2002; Zhang et 
al, 2002; Kawasaki et al, 2003; Myers et al, 2003). These 
pools  compare  favorably  with  chemically  synthesized 
siRNAs in terms of their effectiveness (Myers et al, 2003; 
Myers and Ferrell, 2005a; Myers and Ferrell, 2005b), and 
they  have  been  successfully  applied  to  both  large  scale 
screens  (Liou  et  al,  2005)  and  functional  studies  of 
individual proteins (Fink et al, 2003; Myers et al, 2003; 
Jones et al, 2004; Chi et al, 2006).  
 
Here we address the issue of off-target changes in mRNA 
abundance for Dicer-generated siRNA pools (d-siRNAs) 
and  RNase  III-generated  siRNA  pools  (e-siRNAs).  A 
priori, it seemed possible that the pools might be more 
problematic  than  single  siRNAs,  since  a  typical  diced 
pool  contains  many  different  siRNAs,  each  of  which 
might contribute off-target effects. On the other hand, the  
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low absolute concentration of any individual problematic 
siRNAs  in  a  pool  might  render  their  off-target  effects 
insignificant,  particularly  if  each  problematic  siRNA 
affected  a  different  subset  of  genes.  To  distinguish 
between these two  possibilities, we have examined the 
complexity of diced siRNA pools, and compared the off-
target  effects  of  d-siRNAs  and  e-siRNAs  to  those  of 
three chemically synthesized siRNAs previously shown 
to  elicit  a  range  of  off-target  effects  (Jackson  et  al, 
2003a). We found that d-siRNAs and e-siRNAs produce 
minimal  off-target  effects  as  compared  to  chemically 
synthesized siRNAs. 
 
MATERIALS AND METHODS 
 
Preparation of siRNAs, d-siRNAs, and e-siRNAs 
The 14-1, 14-5, and 14-8 siRNAs (Table 1) were purchased 
from  Ambion  (Austin,  TX)  as  deprotected,  desalted 
duplexes.  The  d-siRNAs  were  prepared  as  previously 
described  (Myers  and  Ferrell,  2005b).  Briefly,  PCR  was 
used to  generate  in vitro  transcription  templates.  The  T7 
promoter (underlined in Table 1) was added to the 5’-end of 
both  the  sense  and  antisense  strand  via  PCR.    Using 
MegaScript  reagents,  T7  polymerase  (Cat.  No.  1334, 
Ambion)  was  used  to  transcribe  the  sense  and  antisense 
RNA  strands,  which  anneal  during  transcription. 
Recombinant human Dicer (Myers and Ferrell, 2005b) was 
used to cleave the large dsRNA into d-siRNA by incubation 
for 16 hr at 37ºC. Recombinant bacterial RNase III (Cat. 
No. 2290, Ambion) was used to cleave large dsRNA into e-
siRNA by incubation for 2 hr at 37ºC as described by the 
manufacturer (Kittler et al, 2005). The Micro-to-midi RNA 
purification  system  (Cat.  No.  12183-018,  Invitrogen; 
Carlsbad,  CA)  was  used  to  purify  the  d-siRNAs  and  e-
siRNAs as described previously (Myers and Ferrell, 2005b). 
 
Cloning individual d-siRNAs 
d-siRNAs  for  human  cyclin  B1  were  generated  from 
bases 820-1479 of the open reading frame as described 
(Myers  and  Ferrell,  2005b).  d-siRNAs  were  cloned 
using a strategy adapted from Elbashir et al (Elbashir et 
al,  2001b).  2  µg  of  d-siRNAs  were  gel  purified, 
extracted  from a  12%  (w/v) urea  gel and  precipitated 
with absolute ethanol. Purified products were ligated to 
5  µM  of  3’  adapter  oligonucleotides  (Dharmacon, 
Lafayette CO) with T4 RNA ligase (NEB), purified, gel 
extracted from a 12% (w/v) urea gel and subjected to 
phosphorylation with T4 polynucleotide kinase (NEB). 
Phosphorylated  products  were  ligated  to  5  µM  of  5’ 
adapter oligonucleotides (Dharmacon) and  purified by 
phenol/chloroform extraction followed by precipitation 
with 10  M ammonium acetate. Ligated products were 
subjected to reverse transcription (Superscript III First-
Strand  Synthesis  Kit,  Invitrogen)  using  3’  oligo 
(5’GACTAGCTGGAATTCAAGGATGCGGTTAAA), 
and  then  amplified  by  PCR  using  5’  oligo 
(5’CAGCCAACGGAATTCATACGACTCACTAAA) 
and  3’  oligo  (5’GACTAGCTGGAATTCAAGGATGC- 
GGTTAAA).  Amplified  products  were  then  cloned  into 
pCR  2.1-TOPO  (Invitrogen),  and  positive  clones  were 
screened by PCR and sequenced using M13 forward and 
reverse primers. 
 
 
Table 1.  siRNAs, d-siRNAs, and e-siRNAs 
 
 
 
siRNA 
 
 
Sense strand 
 
 
Antisense strand 
Position 
relative to  
start codon 
14-1  5’-CCUACAGAGAACUGCGGUUdTdT-3’  5’-AACCGCAGUUCUCUGUAGGdTdT-3’  203-221 
14-5  5’-CCAGUGGCCGAUCCUUAUGdTdT-3’  5’-CAUAAGGAUCGGCCACUGGdTdT-3’  952-970 
14-8  5’-GGCCUUUUCACGGGAACUCdTdT-3’  5’-GAGUUCCCGUGAAAAGGCCdTdT-3’  1129-1147 
GL3  5’-CUUACGCUGAGUACUUCGAdTdT-3’  5’-UCGAAGUACUCAGCGUAAGdTdT-3’  155-173 
 
 
Diced pools 
 
 
Sense primer 
 
 
Antisense primer 
Position 
relative to  
start codon 
d-14-1  5’-GCGTAATACGACTCACTATAGG- 
ATGTCTCAGGAGAGGCCCAC-3’ 
5’-GCGTAATACGACTCACTATAGG- 
GCCGCGTAGCCTGTCATTTC-3’ 
1-551 
d-14-5  5’-GCGTAATACGACTCACTATAGG- 
CACTAGGTGGTACAGGGCTC-3’ 
5’-GCGTAATACGACTCACTATAGG- 
CAGGACTCCATCTCTTCTTGG-3’ 
552-1082 
d-14-8/ 
e-14-8 
5’-GCGTAATACGACTCACTATAGG- 
CCTGGTTTCTGTTCTGTTGATCCC-3’ 
5’-GCGTAATACGACTCACTATAGG- 
TAAGCAAGTTAATCACAGGCTAGTGC-3’ 
1087-1638 
GL3  5’-GCGTAATACGACTCACTATAGG- 
AACAATTGCTTTTACAGATGC-3’ 
5’-GCGTAATACGACTCACTATAGG- 
AGGCAGACCAGTAGATCC-3’ 
114-615  
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Cell culture and transfections 
HeLa cells (Cat. No. CCL-2, ATCC; Manassas, VA) were 
cultured at 37ºC and 5% (v/v) CO2 in Dulbecco’s modified 
Eagle’s  media  (DMEM,  Cat.  No.  11995-65,  Invitrogen) 
containing 10% (v/v) fetal bovine serum (FBS, Cat. No. 
26140-079,  Invitrogen),  100  U/ml  penicillin,  100  µg/ml 
streptomycin, and additional 4  mM  glutamine (Cat. No. 
10378-016, Invitrogen). HeLa cells were plated at ~30% 
confluence whenever a density of ~80% confluence was 
attained  in  order  to  maintain  logarithmic  growth. 
Transfections  were  carried  out  with  GeneSilencer  (Cat. 
No.  T500750,  Genlantis;  San  Diego,  CA)  as  previously 
described (Myers and  Ferrell, 2005b).  Briefly, ~8 x  10
4 
HeLa cells were plated per well in 6-well dishes 18-24 hr 
prior  to  transfection. Shortly before transfection, serum-
containing medium was removed, cells were rinsed twice 
with 2 ml of Opti-mem I (31985-070, Invitrogen) followed 
by addition of 1 ml of Opti-mem I. For most experiments, 
siRNAs,  d-siRNAs,  and  e-siRNAs  were  mixed  with 
GeneSilencer transfection reagents and added to cells such 
that  the  final  concentration  was  10  nM.  Other  final 
concentrations of siRNAs/d-siRNAs/e-siRNAs were used 
for the experiments shown in Figure 1. Three hours and 30 
min after addition of transfection mix, DMEM containing 
20%  (v/v)  FBS,  200  U/ml  penicillin,  200  µg/ml 
streptomycin, and additional 8 mM glutamine was added 
to  each  well  to  restore  each  component  to  normal 
concentrations.  Cells were also  treated  with  transfection 
reagent alone, subjected to the media change to Opti-mem 
I, or left untreated. 
 
 
 
 
 
 
 
 
Figure 1. Complexity of d-siRNA pool.  (A) A 660 bp fragment 
of the human cyclin B1 dsRNA was digested in vitro with human 
recombinant Dicer.  Sixty of the resulting siRNAs were cloned 
and sequenced.  (B) The predicted frequencies of cloning 
individual siRNAs once, twice, three times, or four times, out of 
a sample of 60 clones, for three different assumed pool 
complexities (c=31, 200, 640).  The observed frequencies (open 
circles) fit best to a pool complexity of 200. 
Preparation  of  cellular  extracts  and  purification  of 
total RNA 
The  PARIS  kit  (Cat.  No.  1921,  Ambion)  was  used  to 
produce  total  cellular  extract  and  purify  total  RNA  as 
described  by  the  manufacturer.  About  48  hr  after 
transfection, cells were lysed with cell disruption buffer 
(PARIS)  containing  protease  inhibitors  (Myers  and 
Ferrell,  2005b).  One-third  of  the  lysate  was  saved  for 
analysis  of  protein.  Total  RNA  was  isolated  from  the 
remaining two-thirds. 
 
SDS-PAGE and western blotting 
The  total  amount  of  protein  in  each  cell  lysate  was 
measured with the BCA protein assay kit (Cat. No. 23225, 
Pierce Biotechnology; Rockford, IL). The volume of each 
lysate  was  adjusted  with  cell disruption  buffer (PARIS) 
containing  protease inhibitors such that the total  protein 
concentration of each lysate was equal. After addition of 
Laemmli sample buffer about 15 µg of total protein per 
lane  was  electrophoresed  in  a  10%  (w/v),  29:1 
(acrylamide:bisacrylamide)  SDS  polyacrylamide  gel 
(Myers and Ferrell, 2005b). Proteins were transferred to 
Immobilon-P  polyvinylidine  fluoride  membrane  (PVDF, 
Millipore, Billerica, MA) in 25 mM Tris, 192 mM glycine, 
and  10%  (v/v)  methanol.  Antibodies  were  diluted  in 
Dulbecco’s  phosphate-buffered  saline  (D-PBS,  Cat.  No. 
14040-182, Invitrogen) containing 1% (w/v) non-fat milk 
powder  and  0.01%  (v/v)  Tween-20  (Cat.  No.  P1379 
Sigma-Aldrich;  St.  Louis,  MO).  Affinity  purified  p38α 
MAPK IgG (Cat. No. SC-535, Santa Cruz Biotechnology, 
Santa Cruz, CA) was used at 1:1000 dilution (0.2 µg/ml), 
MEK1  antiserum  662  (Hsiao  et  al,  1994)  was  used  at 
1:2000,  and  affinity  purified  IgG  raised  against  eIF2α 
phosphorylated at serine 51 (cat. No. 44-728G, Biosource 
International; Camarillo, CA) was used at a 1:500 dilution 
(0.5  µg/ml).  Horseradish  peroxidase  (HRP)  conjugated 
goat  IgG  raised  against  rabbit  IgG  (Cat.  No.  81-6120, 
Zymed, San Francisco, CA) was used at a 1:5000 dilution 
(0.3  µg/ml)  for  detecting  MEK1 and  p38α  MAPK  or  a 
1:2500  dilution  (0.6  µg/ml)  for  detection  of 
phosphorylated  eIF2α.  Immun-Star  HRP 
chemiluminescence  kit  (Cat.  No.  170-5040,  BioRad, 
Hercules, CA), a GelDoc (BioRad), and the QuantityOne 
software package (BioRad) were used for visualizing and 
quantifying  MEK1,  p38α  MAPK,  and  phosphorylated 
eIF2α abundance. 
 
Microarray hybridization and data analysis 
Fluorescently-labeled cDNA was synthesized from RNA 
isolated from cells transfected with one of the siRNAs, d-
siRNAs,  or  e-siRNAs.  A  reference  set  of  fluorescently-
labeled cDNAs was prepared from RNA that was isolated 
from HeLa cells treated with the GeneSilencer transfection 
reagent  only.  Comparative  hybridization  to  a  cDNA 
microarray with 41,421 spots from 24,472 unique putative 
genes  (based  on  cluster  ID)  was  then  used  to  identify 
mRNAs  whose  levels  were  different  in  siRNA-treated 
cells compared to the reference control. 
 
To obtain  sufficient quantities  of mRNA for  microarray 
hybridization, polyadenylated transcripts from all samples, 
including  the  reference,  were  amplified  using  the 
MessageAmp  aRNA  kit  (Cat.  No.  1750,  Ambion)  after  
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any residual DNA was removed from isolated total RNA 
with  RNase-free  DNase  provided  in  the  DNA-free  kit 
(Cat. No. 1906, Ambion). Using standard protocols the 
amplified  RNA  (aRNA)  made  from  cells  transfected 
with one of the small dsRNAs was subjected to reverse-
transcription in the presence of random hexamers (Cat. 
No. 27-2166-01, Amersham, Piscataway, NJ) and Cy5-
labeled d-UTP (Cat. No. 55022, Amersham) to produce 
fluorescently  labeled  cDNA  probes.  Similarly  the 
reference aRNA was reverse-transcribed in the presence 
of random hexamers and Cy3-labeled d-UTP (Cat. No. 
53022,  Amersham)  to  produce  a  second  set  of 
fluorescently  labeled  cDNA  probes.  The  fluorescent 
probes  were  then  comparatively  hybridized  (without 
fragmentation)  to  cDNA  micorarrays  as  previously 
described (DeRisi et al, 1997; Wang et al, 2000). 
 
For  each  of  the  54  microarrays,  mRNA  abundance 
measurements  were  independently  normalized  within 
each  array  such  that  the  mean  Cy5:Cy3  ratio  was  1. 
Measurements  of  mRNA  abundance  were  considered 
good if the regression correlation between the Cy5 and 
Cy3 fluorescence intensity across the pixels comprising 
the scanned image of the corresponding array elements 
was greater than 0.6, if the mean intensity of Cy3 was 2-
fold greater than the median background Cy3 intensity, 
and  if  the  Cy5  normalized  mean  intensity  was  2-fold 
greater than the median background Cy5 intensity. 
 
Significance analysis of microarrays (SAM) (Tusher et 
al,  2001)  was  used  to  identify  mRNAs  for  which 
consistent  differences  were  observed  between 
treatments. For Figure 4A, the p38αMAPK siRNAs/d-
siRNAs/e-siRNAs  were  taken  as  one  class  and  were 
compared  to  a  second  class  comprising  the  GL3 
controls.  For  Figure  4B,  ten  separate  SAM  analyses 
were  performed,  with  each  individual  treatment 
considered  to  be  one  class  and  compared  to  a  second 
class  comprising  all  of  the  other  treatments.  Cluster 
analysis (Eisen et al, 1998) was used to organize the heat 
maps. 
 
Complete  microarray  data can  be  found  in  the  Stanford 
Microarray Database (http://genome-www5.stanford.edu/). 
 
RESULTS 
 
d-siRNA pools are highly complex 
We began by estimating the complexity of a diced pool 
of siRNAs. Filpowicz and co-workers have shown that 
recombinant  human  Dicer  prefers  to  cleave  dsRNA 
substrates at their free termini (Zhang et al, 2002). Thus, 
after short periods of digestion the complexity of a diced 
pool  might  be  relatively  low.  However,  for  gene 
silencing  experiments,  in  vitro  dicing  reactions  are 
generally  carried  out  for  long  periods  of  time  to 
maximize  the  yield  of  21  bp  products  (Myers  and 
Ferrell, 2005b). Under these conditions, the complexity 
of the pool could be high. 
 
We diced to completion (16 hr) a 660 bp dsRNA fragment 
derived from the human cyclin B1 open reading frame.  
The d-siRNAs were cloned using a strategy adapted from 
Elbashir et al, and 60 clones were isolated and sequenced. 
The higher the complexity of the 660 bp pool, the lower 
the odds are of obtaining any individual siRNA sequence 
more than once. If the 60 clones sequenced represent a 
random  sample  of  the  pool,  the  Poisson  distribution 
describes  the  odds  of  obtaining  any  individual  siRNA 
sequence,  once,  twice,  or  more  than  twice,  for  any 
assumed complexity. If the complexity is assumed to be 
31 (the minimum number of 21-mers required to span 660 
bp),  then  9/60  sequences  would  be  expected  to  be 
obtained  once,  8/60  twice,  5/60  three  times,  and  so  on 
(Figure  1B).  On  the  other  hand,  if  the  complexity  is 
assumed to be 640 (the maximum number of 21-mers that 
can be obtained from a 660 bp dsRNA), then 55/60 would 
be expected to be obtained once, and 2 or 3 twice (Figure 
1B).  By  fitting  Poisson  distribution  curves  to  the 
experimentally  observed  distribution  of  sequences  and 
minimizing  the  variance  between  the  observed  and 
predicted  distributions,  an  estimate  can  be  obtained  for 
the complexity of the pool. If some siRNAs in the pool 
are easier to clone than others, then the estimate will be a 
lower bound for the true complexity. 
 
As shown in Figure 1A and Supplementary Table 1, the 60 
sequences were distributed throughout the 660 bp dsRNA. 
There was a “hot spot” about 380 nt from the 5’ end of the 
dsRNA, from which 13 of the 60 sequences were cloned. 
This could represent a region of preferred Dicer cleavage 
or  a  region  whose  sequences  were  most  easily  cloned. 
Most of the sequences were 21 nt in length (60%), and 
most of the sequences were obtained only once: 44 were 
isolated once, 5 were isolated twice, 2 were isolated three 
times, and none were isolated more than three times. This 
distribution  yields  an  estimated  complexity  of  200 
different  siRNAs  in  the  pool.  Note  that  if  the  cloning 
process was biased towards particular sequences (like the 
13 “hot spot” sequences), the actual complexity would be 
higher than the estimated complexity.  We carried out a 
similar analysis on a second 660 bp dsRNA, and obtained 
similar  results.  Thus,  diced  siRNA  pools  are  highly 
complex. 
 
Potencies  of  the  synthetic,  diced,  and  RNase  III-
generated siRNAs 
We purchased three p38α MAPK siRNAs that had been 
studied in previously published work (Jackson et al, 2003): 
14-5,  which  was  reported  to  alter  the  levels  of  a  large 
number  of  off-target  mRNAs;  14-8,  which  was 
intermediate in terms of the number of mRNAs affected 
and whose off-target profile was qualitatively distinct from 
that of 14-5; and 14-1, which produced the least severe 
off-target effects (Table 1, Figure 2A). We also transcribed 
three ~550 bp p38α MAPK dsRNAs, (Table 1, Figure 2A) 
and subjected them to digestion with recombinant Dicer. 
In  addition,  one  of  the  three  ~550  bp  dsRNAs  was 
subjected  to  digestion  with  RNase  III.  These  ~550  bp 
regions encompassed each of the three synthetic siRNAs 
(Figure 2A) and contained stretches of identity to various 
p38α MAPK-related genes and to some unrelated genes as 
well. For example, the 551 bp region containing siRNA 
14-1  included  26  consecutive  nucleotides  of  identity  to 
p38β MAPK, 20 nucleotide stretches of identity to p38γ 
MAPK and p38δ MAPK, 17 nucleotides to the alkaline  
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phosphatase  ALPI  and  to  MAP3K7;  the  531  bp  region 
containing  siRNA  14-5  included  20  consecutive 
nucleotides of identity to p38β MAPK, 17 nucleotides to 
the  trithorax-related  gene  MLL,  and  16  nucleotides  to 
ERK1 and p38δ MAPK; and the 552 bp region containing 
siRNA  14-8  included  19  consecutive  nucleotides  of 
identity to MLL, 17 nucleotides to CD44 and the putative 
amidase FLJ31204, 12 nucleotides to p38β MAPK, and 11 
nucleotides to the angiomotin-like gene AMOTL1. Thus 
each long dsRNA region has the potential to produce the 
same  off-target  effects  as  one  of  the  three  synthetic 
siRNAs,  plus  additional  off-target  effects  due  to  cross-
hybridization to a subset of these ten other genes. 
 
 
 
 
 
Figure 2. Silencing p38α MAPK expression with synthetic 
siRNAs, d-siRNAs, and e-siRNAs. (A) Schematic of the p38α 
MAPK cDNA and the sequences targeted by the siRNAs, d-
siRNAs, and e-siRNA employed here. The lengths of the cDNA, 
siRNAs, and pools are drawn to scale. (B) Dose-dependent 
decreases in p38α MAPK protein levels in HeLa cells transfected 
with siRNAs, d-siRNAs, and e-siRNAs. Equivalent amounts of 
whole cell lysates were subjected to SDS-PAGE and 
immunoblotted with MEK1 antiserum (a loading control) or a 
p38α MAPK antibody. (C) Band intensity was quantified, 
normalized to the respective control (a GL3 luciferase-derived 
siRNA as the synthetic control, and Dicer- or RNase III-
generated luciferase d-siRNAs/e-siRNAs as the other controls), 
and plotted as dose/inhibition curves. 
Dicer  produced  a  mix  of  diced  siRNAs  (d-siRNAs)  of 
approximately  21-22  bp,  whereas  RNase  III  produced  a 
mix of siRNAs (e-siRNAs) with a more heterogenous size 
distribution  (15-30  bp)  (data  not  shown).  Various 
concentrations  of  the  synthetic  siRNAs  and  these  d-
siRNA/e-siRNA  pools  were  transfected  into  HeLa  cells. 
As  controls,  we  transfected  a  synthetic  GL3  luciferase 
siRNA (si-GL3), an in vitro diced GL3 control (d-GL3), or 
an RNase III-generated GL3 control (e-GL3). Cells were 
lysed  48  hr  after  transfection  and  lysates  were 
immunoblotted with antibodies against p38α MAPK and 
MEK1, a constant-abundance protein of similar molecular 
mass used as a loading control. 
 
As  shown  in  Figures  2B  and  C,  the  potencies  of  the 
various  siRNAs  and  siRNA  pools  were  similar,  with 
synthetic  siRNA  14-8  and  diced  pool  d-14-8  being  the 
most potent and RNase III-treated pool e-14-8 being the 
least potent. At a final concentration of 10 nM the various 
siRNAs reduced p38α MAPK protein levels by ~50-70%. 
Since this amount of silencing was comparable to those 
attained  in  previous  studies  of  siRNA  off-target  effects 
(Jackson  et  al,  2003)  and  higher  siRNA  doses  may  be 
problematic (Semizarov et al, 2003), we decided to assess 
the off-target profiles of all of the siRNAs and pools at this 
concentration. 
 
Global analysis of mRNA changes 
HeLa cells were transfected in triplicate with p38α MAPK 
siRNAs (14-1, 14-5 or 14-8), d-siRNAs (d-14-1, d-14-5 or 
d-14-8), e-siRNAs (e-14-8), or control luciferase-derived 
siRNAs. Lysates were aliquoted for immunoblot analysis 
(for p38α MAPK, MEK1, and eIF2α, a marker of non-
specific repression of translation) and for global analysis 
of mRNA levels. Each of the p38α MAPK siRNAs and 
pools  produced  a  ~50-70%  decrease  in  p38α  MAPK 
protein  levels  and a  ~30-40%  decrease in  p38α  MAPK 
mRNA levels (Figure 3A). No significant changes in p38α 
MAPK protein or mRNA levels were seen in the control-
treated cells (Figure 3A). None of the treatments elevated 
the levels of eIF2α phosphorylation (Figure 3A), arguing 
that the siRNA-induced decreases in p38α MAPK levels 
were not due to phospho-eIF2α-mediated global inhibition 
of translation. 
 
In the microarray analysis, a total  of 34,944 spots were 
considered well-measured (green channel mean intensity 
>2-fold over green channel median background intensity; 
red  channel  mean  intensity  >2-fold  over  red  channel 
median  background  intensity;  regression  correlation 
between  red  and  green  pixels,  for  each  spot,  >0.6).  Of 
these, 9538 spots, corresponding to 7587 different genes, 
were  measured  in  all  30  arrays  (10  siRNA  treatments 
assessed  in  triplicate).  We  also  carried  out  a  triplicate 
analysis  of  mock-transfected  cells  in  a  separate 
experiment,  with  7257  out  of  the  9538  mRNA  spots 
considered well-measured in all three replicates. As shown 
in  Table  2  and  Figure  3B-E,  the  mock-transfected  cells 
showed little variation in mRNA levels. None of the 7257 
mRNAs changed by more than 2-fold (Table 2), and the 
log-ratio distribution showed a narrow, symmetrical peak 
centered close to zero (Figure 3B-D).  The standard deviat-  
© Myers et al | Journal of RNAi and Gene Silencing | July 2006 | Vol 2, No 2 | 181-194 | OPEN ACCESS 
187 
 
 
 
 
Figure 3. Global changes in gene expression in siRNA-treated cells. (A) Decreases in p38α MAPK mRNA and protein levels.  
mRNA levels were measured by microarray analysis and data from three experiments are shown. Protein levels were also assessed in 
triplicate; one representative blot, showing p38α MAPK levels, MEK1 levels, and eIF2α phosphorylation, is shown here. (B-D) 
Distributions of mRNA levels. (E) Standard deviations of the mRNA distributions. 
 
 
 
ion  of  the  log-ratio  distribution  was  0.17,  which  means 
that 68% of the mRNAs were measured at between 89% 
and 112% of their baseline levels. This can be regarded as 
the  intrinsic  variability  of  the  mRNA  isolation  and 
microarray quantification procedures. 
 
All  of  the  cells  treated  with  siRNAs  showed  somewhat 
greater variation in mRNA levels, as indicated by a slight 
broadening of the log-ratio distribution (Figure 3B-D) and 
an  increase  in  the  distributions’  standard  deviations 
(Figure 3E). These changes were most noticeable in the 
cells treated with two of the synthetic siRNAs, 14-5 and 
14-8  (Figure  3D-E  and  Table  2).  Whereas  none  of  the 
mRNAs changed by more than 2-fold in the mock-treated 
cells and the cells treated with control d-GL3 and e-GL3 
siRNA  pools,  a  total  of  123  mRNA  spots  out  of  9538 
changed  by  more  than  2-fold  in  the  14-5-treated  cells 
(Table  2).  Moreover,  428  mRNAs  out  of  9538  were 
suppressed  to  a  greater  extent  than  the  intended  target, 
p38α  MAPK  (Table  2).  Synthetic  siRNA  14-8  induced 
fewer, but still substantial, changes in mRNA levels; 57 
mRNAs  changed  by  more than 2-fold  and  171  mRNAs 
decreased more than p38α MAPK. 
The remaining synthetic siRNA (14-1) and all of the diced 
siRNAs  exhibited  minimal  global  changes  in  gene 
expression. The number of mRNAs suppressed more than 
p38α MAPK ranged from 18 (for diced siRNA d-14-8) to 
47 (for synthetic siRNA 14-1) out of 9538, and the number 
of mRNAs varying more than 2-fold ranged from one to 
five (Table 2). Thus, in comparison to siRNAs 14-5 and 
14-8, the changes in mRNA levels produced by the diced 
pools were minimal. The RNase III-generated siRNA pool 
(e-14-8) had mild off-target effects (no mRNAs changed 
by more than 2-fold), but because it was the least effective 
at silencing the target p38α MAPK gene, a relatively high 
number of mRNAs were suppressed more than the target 
was (93 out of 9538; Table 2). 
 
Secondary effects and off-target effects 
Some of the changes in mRNA levels could be secondary 
to the suppression of p38α MAPK. Such secondary effects 
would be expected to occur in all of the samples treated 
with  p38α MAPK  siRNAs/d-siRNAs/e-siRNAs,  and  not 
in the samples treated with luciferase siRNAs/d-siRNAs/e-
siRNAs.  To  identify  potential  secondary  changes,  we 
divided the data into two classes, with the d-GL3-, e-GL3-,   
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Table 2. Global changes in mRNA levels in cells treated with diced siRNAs, RNase-III siRNAs and synthetic siRNAs 
 
    GL3 controls  Diced siRNAs  RNase III  Synthetic siRNAs 
  Mock  d-GL3  e-GL3  si-GL3  d-14-1  d-14-5  d-14-8  e-14-8  14-1  14-5  14-8 
Number of 
mRNAs that 
changed more 
than 2-fold 
0  0  0  13  5  4  1  0  1  123  57 
Number of 
mRNAs that 
decreased 
more than 
p38α MAPK 
1820  3653  3330  3329  32  23  18  93  47  428  171 
Number of 
mRNAs that 
changed 
significantly 
by SAM 
-  0±0  4±1  33±1  7±1  9±2  12±1  11±4  35±1  1105±1  322±1 
 
Note: A total of 9538 mRNA spots (corresponding to 7587 different genes) were considered well-measured in all 30 siRNA-treated 
samples. Of those, 7257 spots were also well-measured in the three mock-transfected samples. The ranges shown for the number of 
mRNAs that changed significantly by SAM are calculated from the estimated false discovery rate. 
 
 
 
and si-GL3-treated cells (9 experiments) constituting one 
class and the d-14-1-, d-14-5-, d-14-8-, e-14-8-, 14-1-, 14-
5-, and 14-8-treated cells (21 experiments) constituting the 
other.  We  then  applied  the  significance  analysis  of 
microarrays  (SAM)  method  (Tusher  et  al,  2001),  a 
modified  t-test  that  compares  how  much  an  mRNA 
changes between the two classes to its variability within 
each class,  thereby  identifying mRNAs  whose  between-
class  changes  are  statistically  significant  (Tusher  et  al, 
2001). The mRNAs identified by SAM should include the 
intended target mRNA (p38α MAPK) and any secondary 
mRNAs. 
 
Figure  4A  shows  the  mRNAs  that  decreased  (top)  and 
increased  (bottom)  significantly,  where  we  took  a 
maximum  SAM  q-value  of  25%  as  our  cutoff  for 
significant changes.  The  mRNAs identified included the 
intended  target,  p38α MAPK,  two  other  suppressed 
mRNAs and five induced mRNAs (Figure 4A). At least 
two of the mRNAs (ARK5 and CREB3L1) are connected 
to the p38α MAPK pathway in ways that suggest possible 
feedback roles (positive and negative, respectively). All in 
all, the number of candidate secondary mRNAs was small, 
amounting  to  7  out  of  the  9538  mRNAs  deemed  well-
measured. 
 
To  identify  siRNA-specific  off-target  effects,  we 
performed  ten  SAM  analyses,  with  each  treatment  (3 
experiments)  compared  to  all  other  treatments  (27 
experiments)  and  the  p38α MAPK  mRNA  and  the 
putative secondary mRNAs excluded from consideration. 
The results are shown in Table 2 and Figure 4B. One of 
the treatments, the d-GL3 control, produced no significant 
changes in mRNA levels. Moreover, none of the d-siRNAs 
or e-siRNAs caused more than twelve significant changes 
(Table 2). None of the ten mRNAs mentioned above as 
potentially cross-hybridizing to one or more of the siRNA 
pools  (p38β  MAPK,  p38γ  MAPK,  p38δ  MAPK,  MLL, 
ALPI, MP3K7, ERK1, AMOTL1, CD44, and FLJ31204) 
was found to change significantly. 
 
In contrast, the synthetic siRNAs affected larger numbers 
of  mRNA  levels.  The  si-GL3  control  produced  33 
significant  changes  and  the  p38α MAPK  siRNAs 
produced 35 changes (14-1), 1105 changes (14-5), and 322 
changes  (14-8).  There  was  a  small  degree  of  overlap 
between the mRNAs affected by 14-5 and 14-8, but for the 
most  part  the profiles  of mRNAs were distinct, arguing 
that  the  effects  were  specific  to  particular  siRNA 
sequences  rather  than  shared  by  synthetic  siRNAs  in 
general. For those features we found significant by SAM, 
there was a reasonable correlation between the changes in 
mRNA abundance seen here and those reported previously 
(Jackson et al, 2003), with Pearson correlation coefficients 
of  0.64,  0.54,  and  0.71  for  14-1,  14-5,  and  14-8 
respectively. Note that different luciferase-derived siRNAs 
were used in the two studies and therefore results were not 
compared. 
 
To test the idea that off-target silencing of the siRNAs was 
due to short stretches of sequence identity with the off-
target  mRNAs,  we  characterized  the  degree  of  identity 
between  the  four  synthetic  siRNAs  and  the  173  most 
highly-suppressed  off-target  mRNAs.  Almost  all  of  the 
suppressed  mRNAs  possessed  a  stretch  of  at  least  6 
nucleotides of identity (97%) with the relevant siRNA, and 
almost none of the suppressed mRNAs possessed a stretch 
of 11 or more (1%), with an average of 7.4 + 1.1 (S.D.) 
consecutive  nucleotides.  This  is  consistent  with  the 
possibility  that  short  stretches  of  identity  mediate  the  
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Figure 4. Secondary and off-target effects in cells treated with siRNAs, d-siRNAs, and e-siRNAs. Cells were transfected with 
various siRNAs and pools at a final concentration of 10 nM and were subjected to microarray analysis. (A) Putative secondary 
effects. The samples whose p38α MAPK mRNA was suppressed were compared to the GL3 control samples by significance analysis 
of microarrays (SAM) (Tusher et al, 2001) in order to identify mRNAs whose expression is regulated by p38α MAPK. (B) Off-target 
effects. Ten SAM analyses were carried out, comparing each of the treatments (3 experiments) to the other nine (27 experiments). No 
significant mRNA changes were detected for one of the treatments (d-GL3). For the other treatments, the mRNAs that changed 
significantly are represented as heat maps. The treatment to which each heat map corresponds is indicated on the left; for example, 
the comparison of e-GL3 to the other treatments is shown at the top, and the largest heat map compares the 14-5-treatment to the 
others. Within each heat map, the mRNAs are organized by clustering.  
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off-target  effects.  However,  a  control  group  of  172 
unaffected mRNAs showed the same extent of identity to 
the siRNAs: 98% had a stretch of at least 6 nucleotides, 1% 
had a stretch of 11 or more, and the average was 7.3 + 1.1 
(S.D.). Thus, as a group, the suppressed mRNAs were no 
more likely to possess a long stretch of sequence identity 
with the relevant siRNAs than the unaffected mRNAs were. 
 
Others have also recently shown that exact or near-exact 
matches between either strand of an siRNA and off-target 
mRNAs could not explain the unintentional reduction in 
nontargeted mRNAs (Birmingham et al, 2006). Instead 
one  or  more  exact  matches  between  the  hexamer  or 
hepatamer seed region of the siRNA (positions 2-7 or 2-8 
from  the  5’-end)  and  the  3’-UTR  of  the  off-target 
mRNAs  occurred  at  a  greater  frequency  than  matches 
between the seed region and the 3’-UTR of untargeted 
mRNAs.  Using  the  Birmingham  et  al.  siRNA  seed 
locator  (Birmingham  et  al,  2006),  we  found  that  this 
model can explain at least some of the off-target changes 
we observed. Treatment with 14-5 and 14-8 reproducibly 
decreased  the  abundance  of  239  and  216  different 
transcripts,  respectively  (Table  3).  42  of  the  239 
transcripts unintentionally reduced by 14-5 contained one 
seed  match  in  the  3’-UTR  whereas  only  19  of  240 
randomly chosen transcripts contained a seed match (P < 
0.01 using χ
2 test).  Of these 42 mRNAs, 10 were present 
in a previous study of the effects of 14-5 (Jackson et al, 
2003), and 7 of the 10 decreased in that study as well as 
ours (Supplementary Figure 1). Additionally, 47 of the 
216 mRNAs reduced by 14-8 contained one seed match 
in  the  3’-UTR  in  contrast  to  20  of  the 240  untargeted 
transcripts (P < 0.001 using χ
2 test). Of these 47 mRNAs, 
31 were present in a previous study of the effects of 14-8 
(Jackson et al, 2003), and 20 of the 31 decreased in that 
study  as  well  as  ours  (Supplementary  Figure  1). 
Treatment with the GL3 and 14-1 siRNAs reproducibly 
decreased  the  abundance  of  smaller  numbers  of 
transcripts,  33  and  35  respectively  (Table  3).    In  each 
case three of these untargeted transcripts contained seed 
matches,  which  is  not  significantly  different  from  the 
number  of  matches  in  33  or  35  random  sequences.  
Finally  multiple  seed  matches  in  the  3’-UTRs  of  off-
target  transcripts  were  enriched  relative  to  untargeted 
transcripts  only  in  the  cells  treated  with  14-8  siRNA 
(Table 3). 
 
In summary, a range of off-target effects were seen with 
the synthetic siRNAs; two had relatively minor effects (the 
si-GL3 control and 14-1) and two had marked effects (14-
5  and  14-8).  These  findings  agree  qualitatively  with 
previously  published  findings  (Jackson  et  al,  2003).  In 
contrast, all of the d-siRNA and e-siRNA pools examined 
here were nearly free of off-target effects. 
 
 
 
 
Table 3.  siRNA seed matches to 3’-UTR can explain some but not all siRNA induced off-target effects. 
 
 
                siRNA 
  si-GL3  14-1  14-5  14-8 
Number of single seed matches to 3'UTR 
human genome  1187  1463  4460  4967 
Number  of  multiple  seed  matches  to 
3'UTR human genome  55  124  927  1012 
Number  of  mRNAs  that  were 
significantly reduced (SAM)  34  35  239  216 
Number  of  SAM  mRNAs  with  single 
seed match  3  3  42  47 
Number  of  random  mRNAs  with  single 
seed match 
  1  1  19  20 
P-value (χ
2 test)  1  1  0.01  0.001 
Number  of  SAM  mRNAs with  multiple 
seed match 
  0  0  10  16 
Number of random mRNAs with multiple 
seed match 
  0  0  7  4 
P-value (χ
2 test)  1  1  1  0.01  
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Diluting  siRNAs  into  a  d-siRNA  pool  minimizes  off-
target effects 
We hypothesized that the d-siRNA and e-siRNA pools had 
such minimal off-target effects because each unique siRNA 
within a pool is present at a low absolute concentration. If, 
for  example,  sequence-specific  off-target  effects  are 
mediated by the binding of an siRNA to an eight-nucleotide 
stretch of mRNA sequence, only 15 out of the 529 possible 
22-mers that could be derived from digestion of a 550 bp 
dsRNA (< 3% of the total) would be expected to also match 
that eight-nucleotide sequence. Thus at a total concentration 
of  10  nM  d-siRNA,  the  concentration  of  siRNAs 
complementary to a given eight-nucleotide sequence would 
be  less than  0.3 nM.  This  might  be too  low to result  in 
detectable off-target effects. If more than eight consecutive 
nucleotides of identity are required for off-target effects, the 
absolute concentration of potentially cross-hybridizing 22-
mers would be even lower. 
 
To test these ideas, we added the synthetic siRNA with the 
most  prominent  off-target  effects  (14-5)  to  the 
corresponding diced pool (d-14-5) at dilutions of 1:3, 1:30, 
or 1:300, and then transfected these mixtures in triplicate 
into HeLa cells at a final total RNA concentration of 10 nM. 
We  also  added  the  14-5  synthetic  siRNA  to  a  diced 
luciferase  siRNA  pool  at  the  same  dilutions.  We  then 
analyzed  p38α  MAPK  levels,  MEK1  levels,  and  eIF2α 
phosphorylation levels in all of the samples, and subjected 
cells  transfected  with  14-5,  14-5/d-14-5  mixtures,  and 
various control siRNAs to microarray analysis. 
 
Consistent with previous experiments (Figures 3 and 4), 14-
5,  14-8  and  d-14-5  were  found  to  reduce  p38α  MAPK 
protein levels by 60-70% relative to treatment with d-GL3 
or transfection reagent alone (Figure 5A). Similar silencing 
of  p38α  MAPK  was  seen  in  the  samples  treated  with 
mixtures  of  14-5  and  d-14-5  (Figure  5A).  In  contrast, 
silencing  was  reduced  when  14-5  was  diluted  with  an 
irrelevant diced luciferase control (Figure 5A). The level of 
eIF2α  phosphorylation  was  similar  to  mock  transfected 
cells in all cases (Figure 5A). 
 
We then carried out microarray analysis and focused on the 
mRNAs whose levels had been previously shown to change 
significantly in the 14-5-treated samples (Figure 4B). The 
pattern of mRNA changes induced by 14-5 (Figure 5B) was 
qualitatively similar to that seen in Figure 4B. Dilution of 
the 14-5 siRNA by a factor of 3 with d-14-5 decreased, but 
did not eliminate, this pattern of off-target changes (Figure 
5B) without decreasing the amount of on-target suppression 
the p38α MAPK mRNA (Figure 5A). Dilution of the 14-5 
siRNA by a factor of 30 or 300 with d-14-5 rendered the 
off-target signature undetectable (Figure 5B), again without 
decreasing the amount of suppression of p38α MAPK. We 
noted that in one of the three 1:300 dilution experiments 
there were some changes in mRNA levels (Figure 5B), but 
the changes were irreproducible and distinct from the 14-5 
off-target  signature  and  therefore  were  attributed  to 
experiment-to-experiment variation. Thus, the minimal off-
target effects seen with diced siRNAs can be rationalized on 
the basis of dilution of individual problematic siRNAs to 
insignificant absolute concentrations. 
DISCUSSION 
 
Here we have confirmed previous studies (Jackson et al, 
2003)  showing  that  individual  siRNAs  can  produce 
substantial  off-target  changes  in  mRNA  abundance 
(Figures 4-5). Some of the observed decreases in mRNA 
abundance  may  be  due  to  cross-hybridization  to  seed 
sequences in the off target mRNA 3’-UTRs (Table 3), as 
previously  hypothesized  (Birmingham  et  al,  2006).  In 
support  of this idea, the seed sequences from the  more 
problematic individual siRNAs (14-5 and 14-8) had more 
matches  to  3’-UTR  sequences  than  did  the  least 
problematic individual siRNA (14-1). Other mechanisms 
might explain the observed increases in some mRNAs and 
the  changes  in  the  abundances  of  mRNAs  that  had  no 
obvious cross-hybridization potential. Because these other 
mechanisms  are  incompletely  understood,  it  is  not 
possible to develop siRNA design algorithms that would 
ensure siRNA specificity. 
 
Irrespective  of  the  exact  mechanism(s)  of  off-target 
effects of individual siRNAs, complex d-siRNA pools are 
essentially free of off-target effects (Figure 4), even when 
the diced pool is known to contain a problematic siRNA 
(Figure 5). The simplest explanation for the low off-target 
effects  of  d-siRNAs  is  that  although  an  siRNA  pool 
contains hundreds of different siRNAs (Figure 1), all of 
which would be expected to hybridize with the intended 
target,  very  few  of  them  would  be  expected  to  cross-
hybridize  to  any  particular  off-target  gene  or  to  exert 
some other sequence-specific off-target effect such as an 
aptamer effect. A 1:3 dilution of a problematic individual 
siRNA  caused  a  decrease  in  the  magnitude  of  its  off-
target  effects,  but  higher  dilutions  were  needed  to 
eliminate them (Figure 5) suggesting that the complexity 
of pools is essential to attaining specific gene silencing. 
 
The  low  incidence  of  off-target  effects  in  HeLa  cells 
treated with diced siRNAs agrees well with the general 
impression  of  high  specificity  in  C.  elegans  and 
Drosophila gene silencing, where large dsRNAs, which 
act after being converted to complex pools of siRNAs by 
the  endogenous  Dicer  protein,  are  routinely  used.  The 
minimal  off-target  effects  of  d-siRNAs  make  them  a 
particularly  attractive  method  for  the  transient 
suppression of gene expression in applications like large 
scale  screening  experiments  where  it  might  not  be 
feasible to assess the off-target effects of every siRNA or 
siRNA pool used. 
 
Finally,  it  should  be  emphasized  that  even  when  an 
siRNA or siRNA pool produces no off-target changes in 
mRNA abundance, it is still possible that it will affect the 
translation of off-target mRNAs. Thus, although freedom 
from  off-target  mRNA  effects  is  certainly  desirable  for 
gene  silencing  experiments,  it  is  not  sufficient  to 
guarantee  specificity.  The  use  of  multiple  siRNAs  or 
siRNA  pools,  and  the  rescue  of  an  RNAi-induced 
phenotype  with  an  RNAi-resistant  construct  (e.g.,  a  3’-
UTR-directed d-siRNA pool (like d-14-8) combined with 
a rescue construct lacking the 3’-UTR) remain important 
approaches for  establishing  the specificity  of an RNAi-
induced phenotype.  
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Figure 5. Off-target effects are titratable. (A) Changes in p38α MAPK protein levels. HeLa cells were transfected in triplicate with 
the siRNAs and pools shown, all at a final concentration of 10 nM. One representative immunoblot, showing MEK1 levels (loading 
control), p38α MAPK levels, and eIF2α phosphorylation is shown along with quantitative p38α MAPK data from all three 
replicates. Data are plotted as means + S.D. (B) Fluorescence intensity data from the microarray experiments. The 1105 mRNAs 
identified as changing significantly in the SAM analysis of 14-5 vs. the other treatments (shown in Figure 4B) were used for the heat 
map shown here. Genes that were not well-measured in one or more samples are omitted from the heat map. 
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CONCLUSIONS 
 
• Individual  siRNAs  can  produce  substantial  off-target 
changes  in  mRNA  abundance  as  a  result  of  cross-
hybridization between the seed region of the siRNA and 
the 3’UTR of the off-targeted transcript. 
 
• Other  cross-hybridization  independent  mechanisms 
might  explain  the  increases  in  off-target  mRNA 
abundance but are incompletely understood and therefore 
cannot  necessarily  be  avoided  by  adding  a  feature  to 
siRNA design algorithms. 
 
• Complex d-siRNA pools are essentially free of off-target 
effects even when the diced pool is known to contain a 
problematic siRNA. 
 
• The minimal off-target effects of d-siRNAs make them a 
particularly  attractive  method  for  large  scale,  loss-of-
function screening experiments. 
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 Supplementary Table 1.  Sequences of cloned siRNAs 
 
Nucleotide 
Position 
Sequence  Times 
isolated 
828    GTTGTTGCAGGAGACCATGT  1 
853    ACTGTCTCCATTATTGATCGG  1 
865    ATTGATCGGTTCATGCAGA  1 
868    GATCGGTTCATGCAG  1 
887    ATTGTGTGCCCAAGAAGATGC  1 
893    TGCCCAAGAAGATGCTGCAGCT  1 
897    CAAGAAGATGCTGCAGCTGGTT  1 
906    GCTGCAGCTGGTTGGT  3 
909    GCAGCTGGTTGGTGTCACT  1 
916    GTTGGTGTCACTGCCATGTTT  1 
953    AAGAAATGTACCCTCCA  1 
981    CTTTGCTTTTGTGACTGACAA  1 
982    TTTGCTCTTGTGACTGACAACA  1 
986    CTTTTGTGACT  1 
1028    AGATGGAAATGAAGGTTCTAA  1 
1048    AGAGCTCTAAACTTTGGTCT  1 
1058     ACTTTGGTCTGGGTCGGCC  1 
1061    TTGGTCTGGGTCGGCCTCTAC  2 
1066    CTGGGTCGGCCTCTACCTTTG  2 
1067    TGGGTCGGCCTCTACCTTTGC  1 
1074    GCCTCTACCTTTGCACTTCCT  1 
1103    CATCTAAGATTGGAGAGGTTG  1 
1105    TCTAAGATTGGAGAGGTTGA  1 
1105    TCTAAGATTGGAGAGGTTGATG  1 
1114    GGAGAGGTTGATGTCGAGC  1 
1145    CCAAATACCTGATGGAA  1 
1152    CCTGATGGAACTAACTATG  1 
1169    TGTTGGACTATGACATGGTGC  1 
1176    CTATGACATGGTGCACTTTCC  1 
1185    GGTGCACTTTCCTCCTTCTCA  1 
1190    ACTTTCCTCCTTCTCAAATTG  2 
1192    TTTCCTCCTTCTCAAATTGCAG  1 
1194    TCCTCCTTCTCAAATTGCAGCA  1 
1195    CCTCCTTCTCAAATTGCAGCA  2 
1197    TCCTTCTCAAATTGCAGCAGG  1 
1198    CCTTCTCAAATTGCAGCAGG  1 
1198    CCTTCTCAAATTGCAGCAGGA  1 
1210    GCAGCAGGAGCTTTTTGCTTA  1 
1219    GCTTTTTGCTTAGCACT  1 
1220    CTTTTTGCTTAGCACTGAAAA  1 
1256    AATGGACACCAACTCTACAAC  1 
1300    TCTCTTCTTCCAGTTATGCAG  1 
1335    TGTAGTCATGGTAAATCAAGGA  1 
1342    ATGGTAAATCAAGGA  1 
1390    GCCACATNGAAGCATGC  1 
1398    GAAGCATGCTAAGATCAGC  2 
1413    CAGCACTCTACCACAGCTGA  1 
1447    CAAGATTTAGCCAAGGCTGTGG  1 
1448    AAGATTTAGCCAAGGCTGTGG  3 
1456    GCCAAGGCTGTGGCAAAGGTG  1 
1458    CAAGGGTGTGGCAAAG  1 
 
Note: Nucloetide position is relative to start codon as defined by human cyclin B1 sequence (NM 031966).  
Supplementary Figure 1. Comparison of off-target effects to previous data.  mRNAs whose abundance decreased and 
had a match in their 3’-UTR to the seed region of a particular siRNA were selected from our data and previous data and 
are represented in the form of a heat map (Jackson et al 2003). 